Action 16 | Paediatric HIV

top of page

HIV TREATMENT

2020

Pharmaceutical companies, SRAs, WHO Prequalification Programme (PQ) and NRAs commit to:

Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.

Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.

Paediatric HIV & TB : Rome Action Plan

ACCELERATE

Action 16

Assess acceptability and palatability of formulations for low-resource settings at early stages of the formulations development.

Committed by:

Pharmaceutical companies

Sub-Actions & Milestones

Sub-action 16.1

Assess acceptability and palatability of formulations for low-resource settings at early stages of the formulations development.

Pharmaceutical Companies

Milestone 16.1.1

Document (s)

Updates

Notes

Responsible

bottom of page